UncategorizedNovo Nordisk Seeks to Strengthen Obesity Pipeline With Two Back-To-Back Biobuck Deals Sumain Faisal2 weeks ago01 mins Novo Nordisk expands collaboration with Valo Health for cardiometabolic drugs and partners with Variant Bio on metabolic disease targets. read more Post navigation Previous: Why Citius Pharmaceuticals (CTXR) Stock Is Down 15%Next: MSC Industrial Beats Q1 Estimates, Eyes Long-Term Growth Amid Near-Term Challenges Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Dow Jumps Over 500 Points As Trump Takes Office: Investor Sentiment Improves, But Greed Index Remains In ‘Fear’ Zone Sumain Faisal3 hours ago 0
Ford Mustang Architect Hal Sperlich Dies At 95: ‘Lot Of People Who Make Great Cars But So Few Who Invent Segments Like Hal Did,’ Says Jim Farley Sumain Faisal3 hours ago 0
Whale Investor Snaps Up $5 Million In Official Trump Coin Minutes After President Says, ‘I Don’t Know Much About It,’ Marking One Of The Largest Purchases Since Launch Sumain Faisal4 hours ago 0